Ashwani Verma Stock Analyst Profile - UBS Research Coverage - Stocknear

Ashwani Verma

Stock Analyst at UBS

(4.59)
# 1404
Out of 5,493 analysts
93
Total ratings
Success rate
Average return

24 Stocks

Name Action PT Current % Upside Ratings Updated
TEVA Teva Pharmaceutical ...
Maintains: Strong Buy
23 26
18.34 41.77% 10 Sep 24, 2025
BHVN Biohaven
Maintains: Buy
27 26
15 73.33% 4 Sep 16, 2025
ACAD ACADIA Pharmaceutica...
Maintains: Strong Buy
36 39
21.05 85.27% 7 Sep 9, 2025
UTHR United Therapeutics
Maintains: Strong Buy
415 560
432.64 29.44% 7 Sep 4, 2025
AVDL Avadel Pharmaceutica...
Maintains: Strong Buy
13 20
15.34 30.38% 3 Aug 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
43 38
39.04 -2.66% 4 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 18
16.23 10.91% 1 Jul 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
152 174
142 22.54% 9 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 54
33.37 61.82% 3 Jul 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
33 42
27.89 50.59% 5 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
61 61
82.7 -26.24% 1 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
47 41
50.4 -18.65% 5 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 48
27.51 74.48% 2 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
1.5 -30% 5 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
145 179
127 40.94% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
106 114
79.75 42.95% 2 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
83 79
n/a n/a 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
107 105
116.76 -10.07% 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28
35.04 -20.09% 3 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 7
107.01 -93.46% 1 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
209
n/a n/a 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
9 12
9.52 26.05% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
n/a n/a 1 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
137 71
n/a n/a 3 Aug 4, 2022